Press Release: PSG : Pharmaceutical Strategies Group to Detail Cost-Effective Options for Pharmacy Benefit Plans at IFEBP Annual Conference

HONOLULU--(BUSINESS WIRE)--Fast-rising drug costs and complicated pharmacy benefit plans can be puzzling for employers and employee benefits representatives. But Pharmaceutical Strategies Group (PSG), the largest independent pharmacy program consulting firm in the U.S., can help put together the pieces for a cost-effective and health-focused pharmacy benefit plan. PSG will have four executives available to discuss the challenges and options during the International Foundation of Employee Benefi

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Dave Borden's photo - CEO of Pharmaceutical Strategies Group, LLC


Dave Borden

CEO Approval Rating


PSG is a provider of benefit consulting and data analytics services to the pharmaceutical sector. Read more